BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai X, Ali A, Wang N, Liu Z, Lv Z, Zhang Z, Zhao X, Hao H, Zhang Y, Rahman FU. Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies. Eur J Med Chem 2022;227:113920. [PMID: 34742012 DOI: 10.1016/j.ejmech.2021.113920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Todorov L, Kostova I. Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs. Molecules 2023;28. [PMID: 36838947 DOI: 10.3390/molecules28041959] [Reference Citation Analysis]
2 Han L, Dai W, Luo W, Ye L, Fang H, Mo S, Li Q, Xu Y, Wang R, Cai G. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer. Cancers (Basel) 2023;15. [PMID: 36765520 DOI: 10.3390/cancers15030562] [Reference Citation Analysis]
3 Lim INX, Nagree MS, Xie SZ. Lipids and the cancer stemness regulatory system in acute myeloid leukemia. Essays Biochem 2022:EBC20220028. [PMID: 35996953 DOI: 10.1042/EBC20220028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhao Q, Lin X, Wang G. Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front Oncol 2022;12:952371. [DOI: 10.3389/fonc.2022.952371] [Reference Citation Analysis]